Results 221 to 230 of about 28,512 (352)

Comparative Efficacy of Hemostatic Agents in Dermatologic Surgery: A Systematic Review

Isabella Ribaudo, Katelyn Vlastaris, Michelle Bongiorno, Mark Biro, Pooja H. Rambhia, Neil Nero, Micah Belzberg, Christine Poblete-Lopez   +7 more
openalex   +2 more sources

Use of a novel agent to decrease bleeding and bruising associated with dermatologic surgery

, 2016
Barry A. S. Lycka
openalex   +1 more source

Psychometric evaluations of the simplified Chinese version of the Functional Assessment of Cancer Therapy-Epidermal Growth Factor Receptor Inhibitors 18 (FACT-EGFRI-18-sC) for measuring dermatologic toxicities in metastatic colorectal cancer patients treated with EGFRIs. [PDF]

Health Qual Life Outcomes
Zhang L, Ni N, Wu L, Zhou L, Ning S, Liu C, Wang T, Benjamin Tan JY, Sun D, Zhang H, Shi X, Ma Y, Zhao Z, Jiang N, Wang M, Tian X, Xu H, Liu L.   +17 more
europepmc   +1 more source

Unravelling the Major Cardiovascular Risks of Systemic Psoriasis Medications: A Literature Systematic Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Psoriasis is a chronic inflammatory dermatological condition associated with an elevated risk of cardiovascular events (CVEs). Systemic therapies have transformed disease management, but their cardiovascular (CV) safety profiles remain incompletely understood and inconsistently reported.
Mai Thi Hoai Son, Yves Julien Mbama Biloa, Pauline Gouttefarde, Thomas Franck, Gilles Cizeron, Mathieu Oriol, François Maccari, Elisa Cinotti, Beatrice Trombert‐Paviot, Bienvenu Bongue, Jean‐Luc Perrot   +10 more
wiley   +1 more source

Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor

, 2016
Viswanath Reddy Belum, Benjamin Benhuri, Michael A. Postow, Matthew D. Hellmann, Alexander M. Lesokhin, Neil H. Segal, Robert J. Motzer, Shenhong Wu, Klaus J. Busam, Jedd D. Wolchok, Mario E. Lacouture   +10 more
openalex   +1 more source

How will we treat systemic lupus erythematosus in the next 5 years? [PDF]

Rheumatol Immunol Res
Zhao J, Tian X, Li M, Zeng X.
europepmc   +1 more source

Low Dose Pegylated Interferon Alpha as a First‐Line Treatment for Necrobiotic Xanthogranuloma

JEADV Clinical Practice, EarlyView.
ABSTRACT Necrobiotic xanthogranuloma (NXG) is a rare, progressive granulomatous disorder frequently associated with monoclonal gammopathy, particularly monoclonal gammopathy of undetermined significance (MGUS). It typically presents with indurated to ulcerative yellowish plaques or nodules, often with ocular involvement.
Ishana Dixit, Charmaine Vanessa S. Chamberlin, Pablo Fernandez‐Peñas   +2 more
wiley   +1 more source

Bridging the cost divide: comparing veterinary and human dermatologic drug pricing in the US. [PDF]

Proc (Bayl Univ Med Cent)
Dowdle TS, Schmidt M, Remmert N, Munoz A.   +3 more
europepmc   +1 more source

Characteristics of Adult Patients With Atopic Dermatitis Initiating Biologics and Janus Kinase Inhibitors in the CorEvitas Atopic Dermatitis Registry

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Biologics and Janus kinase inhibitors (JAKi) are two advanced systemic treatment options for patients with atopic dermatitis (AD). The decision to initiate one of these therapies is complex and may be driven by many factors.
Eric L. Simpson, Linda Stein Gold, Seemal R. Desai, Alexandra K. Golant, Douglas DiRuggiero, Christian Fenske, Yolanda Muñoz Maldonado, Alvin H. Li, Zach Dawson, Kaylee Ho, Kayla Callahan, Gaia Gallo, Jonathan I. Silverberg   +12 more
wiley   +1 more source

A review on delayed toxic effects of sulfur mustard in Iranian veterans [PDF]

core   +1 more source